Signal More than 400 billion dollars of pharma commitments to US facilities create a new AI testbed
Summary
CB Insights sums 2025 announcements by the ten largest committers into a US R&D and manufacturing build exceeding 400 billion dollars, and treats the resulting greenfield as a reset moment for how laboratories are designed around AI.
Classification
Main topicIndustry & Supply Chains
Region menusNorth America
Occurrencescope:country · geo_region:north_america · country:US
Impactscope:country · geo_region:north_america · country:US
Time horizon4-10 years (2026-07-26)
Last updated2026-07-29 04:49:53
Evidence 1
- 2026 Tech Trends CB Insights page=48;section=Health & bio / Pharma's path to self-driving labs 2026-01 accessed 2026-07-26
Part of trends 1
Directly linked issues 0
No objects.
Relation types: supports
Public id: fm-870d12d1e784